Corey Siegel, MD, on Positioning JAK Inhibitors in IBD Management
06/23/2010
In this video, Corey Siegel, MD, previews his talk on positioning Janus-kinase inhibitors and small molecules for treating inflammatory bowel disease, which he will be presenting at the Advances in Inflammatory Bowel Disease 2020 virtual regional meeting on June 27. Read the full transcript here.
Corey Siegel, MD, is section chief of gastroenterology and hepatology at Dartmouth-Hitchcock Medical Center in New Hampshire.
For more information about AIBD 2020 Regionals and to register for upcoming sessions, visit https://www.aibdregionals.com.
